Clinical Trial Update: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating endoscopic ultrasound-guided ethanol with paclitaxel ablation for pancreatic mucinous cystic neoplasms was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucinous Cystic Neoplasm of the Pancreas

Drugs mentioned

• Ethanol (ethanol)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Mucinous Cystic Tumor With Moderate Dysplasia, Mucinous Cystadenoma of Pancreas | Phase 1 | Status: TERMINATED